Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMS5552 plus metformin in type 2 diabetes mellitus inadequately controlled on metformin
CTR20170444Phase 3Completed
- Sponsor
- Hua Medicine
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dorzagliatin in type 2 diabetes mellitus (T2DM), sponsored by Hua Medicine. Started Aug 2017; status: completed.
02
Drugs
dorzagliatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20170444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170444.